Join us, Thomas Reichart and Justin Tomlinson, as we sit down with Dr. Christian Muehlendyck, the lead for the Scientific Partnerships of J&J MedTech in EMEA, and special guest host Dr. Wolfgang Golisch to discuss the future of healthcare through the lens of data-driven innovation.

Dr. Christian Mühlendyck is the Scientific Partnerships Lead for J&J MedTech EMEA. Within this role he is also the industry coordinator of the IHI funded IDERHA consortium.

IDERHA aims to addresses the obstacles in accessing and analyzing health data to maximize their value for patient care and medical research by building one of the first pan-European health data spaces. To enable patients and healthcare providers to benefit from innovative health solutions, it also seeks to accelerate policy developments of real-world evidence acceptance for regulatory approval and Health Technology Assessments (HTA).

His expertise in health research and digital health combined with his clinical and long leadership experience fuel this significant initiative.


For more details and to follow IDERHA:
Web: http://www.iderha.org
LinkedIn: https://www.linkedin.com/company/iderha/?lipi=urn%3Ali%3Apage%3Ad_flagship3_search_srp_all%3BgjBPph06TUCprghD9PG2HQ%3D%3D

Innovative Health Innitiative : IHI

Katerina Sakkoula stands at the intersection of healthcare innovation and effective implementation. As the Head of Affiliate Global Interface at Roche, she and her team are at the forefront of elevating patient safety globally. Katerina offers an important perspective on the transition from sick care to healthcare. Join hosts Thomas and Justin as they explore not only her professional journey, what drives her, where she finds joy, and her vision for the future of healthcare.

Cordula Keppler is a Safety Network Insights Leader for Advanced Therapy Medicinal Products and Non-Onco Hematology at Roche.

With extensive experience in various functions within Roche, including Medical Affairs, Patient Safety, and Regulatory, has given her a systems perspective for the future of healthcare.One of Cordula's most exciting, and personal, contributions is her work with Roche's MedWallet, a groundbreaking therapy accompanying app that is transforming the way patients manage their medications and healthcare information. MedWallet provides a centralized platform where patients can access vital information about their ongoing medications, keep track of their medical care team, and seamlessly share this information with family, friends, and healthcare professionals whenever needed.

In this episode, Thomas and Justin have the pleasure of speaking with Dr. Lisa Egbuonu-Davis, MD, MPH, MBA, Vice President of Medical Innovations at Danaher Diagnostics, about the critical role of social determinants in healthcare outcomes. Dr. Egbuonu-Davis is an accomplished global pharma and public health expert, passionate about advocating for equity in healthcare and education, focusing on diversifying the STEM pipeline and expanding the inclusion of minority talents in these fields. With her unique ability to bridge the gap between science and business, Dr. Egbuonu-Davis has led innovative product development that have positively impacted multiple stakeholder communities. She also brings valuable board leadership experience, serving on the board of directors for Omega Healthcare Investors, Avanos Medical, Johns Hopkins Medicine, and the National Advisory Council for the School of Education

Steven's newly released book, "Creative Together," details the mindset and behavior shifts needed to bring conscious creativity to our time's most pressing and urgent challenges. Through his firm, Creative LicenseTM Consulting Services, he works with clients to shape organizational cultures and reinvigorate how teams co-create new value. As a coach, speaker, and consultant partner, he facilitates the creativity of scientists, engineers, business leaders, and professionals across industries. Listen and gain a deeper understanding of the potential you have been gifted.

Boris Zaïtra is the Head of Group Business Development and Mergers and Acquisitions at Roche. Boris has a front-row seat to the changing landscape of healthcare. He and his team focus on structuring deals in service of the long-term strategy to bring in the external innovation: as such he has an insightful view of the trends, value drivers, and direction of our global healthcare system.

Stone, Douglas, et al. Difficult Conversations: How to Discuss What Matters Most. Portfolio Penguin, 2011.

Note: for subscribers who downloaded this episode as soon as it was released: a short excerpt from the episode was mistakenly released in lieu of the full episode. This episode is the full, updated version. Please email madeline.may@valueaddgroup if you have any questions. Thanks!

Dr. Sabah Oney is a Biotech Executive, Board Member, and Venture Partner. Sabah thinks big when it comes to addressing the unmet needs of patients. His commitment to mobilizing people, and resources around bold scientific ideas and possibilities that impact society is inspiring.

“The credit belongs to the man who is actually in the arena… who at the best knows in the end the triumph of high achievement, and who at the worst, if he fails, at least fails while daring greatly, so that his place shall never be with those cold and timid souls who neither know victory nor defeat.” - Teddy Roosevelt

Quote: "Be ashamed to die until you have won some victory for humanity." - Horace Mann

Book recommendation: Endurance by Alfred Lansing

Bea Lavery is Vice President at Genentech/Roche, Global Head of Oncology Regulatory Affairs. Simply put, Bea is an extreme value creator. Her ability to mobilize people around ideas that matter is well known and regarded. If you could see her network constellation, you would see she is the north star for a broad range of people.